Ionis Pharmaceuticals | IONS - أصول متداولة





أصول متداولة تغيير تاريخ
Agios Pharmaceuticals USD 942.05M 91.06M 2025-12
Alnylam Pharmaceuticals USD 4.05B 97.85M 2025-12
Arrowhead Research USD 1.17B 223.75M 2025-12
Astellas Pharma JPY 1.44T 72.43B 2025-12
BioCryst Pharmaceuticals USD 404.35M 48.66M 2025-12
BioMarin Pharmaceutical USD 3.95B 98.95M 2025-12
Celltrion KRW 5.54T 291.68B 2025-09
Cspc Pharmaceutical CNY 22.61B 721.94M 2025-06
Deva Holding AS TRY 9.13B 1.61B 2023-09
Divis Laboratories Ltd INR 98.43B 2.38B 2025-09
Esperion Therapeutics USD 462.57M 102.11M 2025-12
Exelixis USD 1.44B 41.03M 2025-12
Halozyme Therapeutics USD 825.21M 503.54M 2025-12
Ionis Pharmaceuticals USD 2.99B 471.01M 2025-12
Kangmei Pharma CNY 7.03B 128.34M 2025-09
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Laboratorios Farma EUR 509.33M 128.63M 2023-12
Malin Corporation EUR 62.6M 26.7M 2024-12
Medical Developments International AUD 33.75M 1.79M 2025-12
Moderna USD 6.54B 54M 2025-12
Nektar Therapeutics USD 281.36M 94.79M 2025-09
Neuren Pharmaceuticals AUD 332.23M 11.98M 2025-12
Neurocrine Biosciences USD 2.52B 364.3M 2025-12
Novartis USD 30.46B 2.26B 2025-12
Omeros USD 69.65M 26.53M 2025-06
OPKO Health USD 581.88M 45.25M 2025-12
Organigram Holdings CAD 256.54M 28.35M 2025-12
Ovoca Bio EUR 4.96M 2.06M 2022-06
Pfizer USD 46.92B 3.22B 2025-09
Pharma Mar EUR 283.41M 40.53M 2025-12
PTC Therapeutics USD 2.27B 266.14M 2025-12
Qiagen NV USD 2B 535.87M 2025-12
Regeneron Pharmaceuticals USD 18.02B 41.2M 2025-12
Roche Holding CHF 38.73B 3.03B 2025-12
Sarepta Therapeutics USD 2.54B 184.37M 2025-12
Sartorius EUR 1.72B 449M 2025-09
Sino Biopharmaceutical CNY 33.82B 9.13B 2025-06
Tilray USD 729.32M 28.18M 2025-09
Ultragenyx Pharmaceutical USD 643.21M 76.58M 2025-09
Vertex Pharmaceuticals USD 11.2B 631.4M 2025-12
Zealand Pharma A/S 15.67B 950.94M 2025-12
Zz Pientze Pharmaceu CNY 10.7B 1.59B 2025-09